Abstract
. Variability in biomarker of exposure levels in smokers in a study of smokers switched to reduced toxicant prototype cigarettes. Christopher J. Shepperd1, Alison Eldridge1, Graham Errington1, Oscar M Camacho1, Kevin McAdam1, Ingo Meyer2 and Christopher J. Proctor1* 1British American Tobacco, Group Research & Development, Regents Park Road, Southampton, SO15 8TL, United Kingdom 2Momentum Pharma Services, Hamburg, Germany *Correspondence: christopher_proctor@bat.com
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
